177 related articles for article (PubMed ID: 29350683)
21. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
22. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
[TBL] [Abstract][Full Text] [Related]
23. Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer.
Qu Y; Gharbi N; Yuan X; Olsen JR; Blicher P; Dalhus B; Brokstad KA; Lin B; Øyan AM; Zhang W; Kalland KH; Ke X
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9339-44. PubMed ID: 27482107
[TBL] [Abstract][Full Text] [Related]
24. TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells.
Huang G; Wang M; Li X; Wu J; Chen S; Du N; Li K; Wang J; Xu C; Ren H; Tang SC; Sun X
Life Sci; 2019 Sep; 232():116630. PubMed ID: 31279783
[TBL] [Abstract][Full Text] [Related]
25. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
26. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
27. Let-7c restores radiosensitivity and chemosensitivity and impairs stemness in oral cancer cells through inhibiting interleukin-8.
Peng CY; Wang TY; Lee SS; Hsieh PL; Liao YW; Tsai LL; Fang CY; Yu CC; Hsieh CS
J Oral Pathol Med; 2018 Jul; 47(6):590-597. PubMed ID: 29582468
[TBL] [Abstract][Full Text] [Related]
28. Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency.
Song Z; Wang H; Zhang S
Biomed Pharmacother; 2019 Oct; 118():109336. PubMed ID: 31545260
[TBL] [Abstract][Full Text] [Related]
29. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
30. Highly expressed lncRNA LOC730101 promotes lung cancer cell growth through Wnt canonical pathway.
Liu L; Zhang Y; Cao W
Biochem Biophys Res Commun; 2017 Nov; 493(2):992-997. PubMed ID: 28943432
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
[TBL] [Abstract][Full Text] [Related]
32. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
Rong L; Zhao R; Lu J
Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
34. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer.
Kitamura H; Okudela K; Yazawa T; Sato H; Shimoyamada H
Lung Cancer; 2009 Dec; 66(3):275-81. PubMed ID: 19716622
[TBL] [Abstract][Full Text] [Related]
36. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
37. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
[TBL] [Abstract][Full Text] [Related]
38. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
[TBL] [Abstract][Full Text] [Related]
39. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
40. Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.
Zhang X; Lou Y; Wang H; Zheng X; Dong Q; Sun J; Han B
Med Oncol; 2015 Apr; 32(4):95. PubMed ID: 25731617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
